stars 1 stars 2 stars 3

Bioimics is a Swedish biotechnology company focusing on development of novel antibacterial compounds, ribozyme inhibitors, for the treatment of Healthcare Associated Infections.

Bioimics AB Questions

The Bioimics AB annual revenue was $1 million in 2026.

Bioimics AB is based in Uppsala, Uppsala.

The NAICS codes for Bioimics AB are [541713, 541, 5417, 54171, 54].

The SIC codes for Bioimics AB are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users